Skip to content

Measurement of neuropsychological effects of SOYLAX on healthy volunteers.

Measurement of neuropsychological effects of SOYLAX on healthy volunteers. - Measurement of neuropsychological effects of SOYLAX on healthy volunteers.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057565
Enrollment
28
Registered
2025-04-09
Start date
2025-03-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Phase I: Taking experimental food for 3days (once a day) Wash out phase: About 1 week or more Phase II: Taking three times control food Phase I: Taking three times control food Wash out phase:

Sponsors

UHA Mikakuto Co., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Healthy adult men and women (not suffering from any disease) between the ages of 18 and 65 at the time of obtaining consent. 2) Persons who have received a full explanation of the study, are able to understand its contents, and are able to give their consent.

Exclusion criteria

Exclusion criteria: 1) Those who may develop abdominal pain due to materials containing soybeans 2) Those who regularly use materials containing soybeans (3 days or more per week) and those who have regularly used such materials within 3 months prior to the pre-test 3) Those who have been diagnosed with malignant tumors, those who are undergoing treatment for cranial nerves, heart disease, kidney disease, diabetes, thyroid dysfunction, or have a history of liver disease or other serious diseases. However, this excludes diseases such as hypertension treatment, which are judged by the project manager to have no impact on the evaluation of this study. 4) Those who drink large amounts of alcohol (daily equivalent of 60 g of alcohol or more: about 1500 mL of beer, 540 mL of wine, 3 g of sake, or 180 mL of whiskey double) 5) Those who are at risk of developing allergies related to the study foods. 6) Those who are judged to be unsuitable as subjects based on their answers to the lifestyle questionnaire 7) Participants who have participated in other clinical studies within one month prior to obtaining consent to participate in this study, or who are scheduled to participate in other clinical studies after obtaining consent to participate in this study. 8) Other subjects who are judged to be inappropriate by the investigator.

Design outcomes

Primary

MeasureTime frame
The changes in the mood scale before and after consumption of the test foods will be compared using the VAS.

Secondary

MeasureTime frame
[Efficacy] Measuring the neuropsychological effects of the test food by comparing mood scales after ingestion of the test food and after ingestion of the control food.

Countries

Japan

Contacts

Public ContactYasuhiro Kashima

UHA Mikakuto Co., LTD. Global Heallthcare Research Laboratory

kasimay@uha-mikakuto.co.jp0667676050

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026